Welcome, Guest
Username: Password: Remember me
CYTX Financial performance development
  • Page:
  • 1

TOPIC: Nasdaq Listing

Nasdaq Listing 11 Jun 2018 11:36 #11932

  • fas
  • fas's Avatar Topic Author
  • Offline
  • Moderator
  • Moderator
  • May the fat be with you
  • Posts: 3358
  • Thank you received: 1116
Just for the record-

On June 8, 2018, Cytori Therapeutics, Inc. (the “Company”) received written notice from The Nasdaq Stock Market that the Company has regained compliance with the Nasdaq Stock Market Listing Rule 5500(a) (2) concerning its minimum bid price per share of the Company’s common stock. Accordingly, the Company's common stock will continue to be listed on The Nasdaq Capital Market, and the listing qualification matters previously disclosed by the Company have been closed. 

Please Log in or Create an account to join the conversation.

Board moderator and Site-owner. I still regret the day I started analysing the prospects of MacroPore (now Cytori) back in 2004- a left-over from the tech-bubble at that time from the century change in my portfolio- and became addicted to Cytori´s fat cell technology. :cry:
  • Page:
  • 1
Time to create page: 0.069 seconds

Copyright Information

Copyright Fas Kuiters © 2016 young-foxes.com. All Rights Reserved.
This page is made with Joomla CMS and its various templates designed by Fas Kuiters with the excellent Themler tool.



Shared Spreadsheet Links

DOV´s Revised Projections for the Periods 2017 until 2020

Shareble link : HERE

Fas Kuiters Websites